Medco Spinoff Plan Revised; PBM Margins Look Healthier In 2003
The one-year delay in Merck's Medco spinoff means that the pharmacy benefit manager will begin operations as a separately traded public company with a healthier gross margin
The one-year delay in Merck's Medco spinoff means that the pharmacy benefit manager will begin operations as a separately traded public company with a healthier gross margin